SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001144204-14-019848
Filing Date
2014-04-01
Accepted
2014-04-01 14:02:34
Documents
1
Period of Report
2013-12-31
Effectiveness Date
2014-04-01

Document Format Files

Seq Description Document Type Size
1 NT 10-K v373549_nt10k.htm NT 10-K 22242
  Complete submission text file 0001144204-14-019848.txt   23410
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-15070 | Film No.: 14733418
SIC: 2834 Pharmaceutical Preparations